Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome.
N Engl J Med. 2010 Sep 16;363(12):1107-1116
Authors: Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, GuÃ©rin C, Prat G, Morange S, Roch A
The investigators induced muscle paralysis in patients with the acute respiratory distress syndrome (ARDS) by administering a neuromuscular blocking agent, cisatracurium besylate. As compared with placebo, cisatracurium resulted in a lower adjusted 90-day mortality without more severe sequelae of neuromuscular blockade.
PMID: 20843245 [PubMed - as supplied by publisher]